SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/AB4BAEF496375A4058C85D010C9D57C1B1206D169683C9E36F3488A893226AB9A58C4B94D7C69B50FC8DC5D1A75B98CE>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/AB4BAEF496375A4058C85D010C9D57C1B1206D169683C9E36F3488A893226AB9A58C4B94D7C69B50FC8DC5D1A75B98CE
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/AB4BAEF496375A4058C85D010C9D57C1B1206D169683C9E36F3488A893226AB9A58C4B94D7C69B50FC8DC5D1A75B98CE
http://www.w3.org/2000/01/rdf-schema#comment
"Activated/phosphorylated pMAPK 44/42 was detected in 82% of medulloblastomas all subtypes and in 62.5% of primitive neuroectodermal tumors with coexpression of SSR1 in one third."
xsd:string
http://purl.uniprot.org/uniprot/#_440730070167FF0F133BCCC2BDA0B7EEE573CAE673D3899E4D5F96E8F303C6517D22FD0D880FED8F1BFF2B9734A3431C
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/AB4BAEF496375A4058C85D010C9D57C1B1206D169683C9E36F3488A893226AB9A58C4B94D7C69B50FC8DC5D1A75B98CE
http://purl.uniprot.org/uniprot/Q86SW9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/AB4BAEF496375A4058C85D010C9D57C1B1206D169683C9E36F3488A893226AB9A58C4B94D7C69B50FC8DC5D1A75B98CE
http://purl.uniprot.org/uniprot/#_Q86SW9-mappedCitation-23455179
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/AB4BAEF496375A4058C85D010C9D57C1B1206D169683C9E36F3488A893226AB9A58C4B94D7C69B50FC8DC5D1A75B98CE